Sara Rattik
Malmoe, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion.
Journal: Journal of the American Heart Association
Published: May 15, 2025
Author Correction: Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.
Journal: Nature communications
Published: February 12, 2025
IL1RAP Blockade With a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis.
Journal: Circulation. Heart failure
Published: November 08, 2024
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: October 21, 2023
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling.
Journal: Cell reports
Published: October 17, 2023
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.
Journal: Nature communications
Published: June 23, 2023
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
Journal: Cardiovascular research
Published: March 14, 2023
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia.
Journal: NPJ aging and mechanisms of disease
Published: November 09, 2020
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.
Journal: Vascular pharmacology
Published: August 19, 2020
Liver X receptors are required for thymic resilience and T cell output.
Journal: The Journal of experimental medicine
Published: February 20, 2020
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice.
Journal: Circulation
Published: May 29, 2019
Last Updated: 09/26/2026